- Rachel Filipiak
- SARA BAKKEN
- Alyssa Pitterle
Fellows are responsible for organization of this conference, where an unknown case is presented to the attending physicians who then discuss differential diagnosis, diagnostic evaluation, and initial treatment recommendations. Following this discussion, the findings and outcome are presented by the fellow, after which he/she presents an in-depth review of the literature pertaining to the case.
MD, DO, RN, APRN, LPN, Pharmacists, Pharmacy Technicians, PA, social workers, PhD, medical students
|David Andes, MD, Chair||Rachel Filipiak, Coordinator||Amy Gentry, APP||Sara Bakken, MS, ND, Coordinator|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .01 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
- Identify best clinical practices based on current literature in the field of infectious disease.
- Apply robust clinical judgement to their practices related to advance in the field of infectious diseases.
- Identify strategies to improve communication among team members in order to standardize care.